Bleomycin therapy and Anaesthesia
- 1 January 1981
- journal article
- Published by Wiley in Anaesthesia
- Vol. 36 (1) , 60-63
- https://doi.org/10.1111/j.1365-2044.1981.tb08602.x
Abstract
Bleomycin is a cytotoxic drug used in the treatment of teratoma of the testis. This drug appears to sensitize the lungs so that acute lung damage occurs with concentrations of oxygen normally considered free from toxic effects. Two anaesthetics administered to the same patient undergoing thoracotomy are reported. No postoperative lung damage was produced on either occasion.Keywords
This publication has 10 references indexed in Scilit:
- Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.BMJ, 1978
- Pulmonary complications after bleomycin, irradiation and surgery for esophageal cancerCancer, 1978
- Phase II evaluation of bleomycin.A Southwest Oncology Group studyCancer, 1976
- Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue responsePublished by American Medical Association (AMA) ,1976
- Large-Dose Bleomycin Therapy and Pulmonary ToxicityPublished by American Medical Association (AMA) ,1976
- Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapyJAMA, 1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Acute Bleomycin Lung1,2American Review of Respiratory Disease, 1972
- Interstitial Pneumonitis Associated with Bleomycin TherapyAmerican Journal of Clinical Pathology, 1972
- The Toxicity of OxygenAnesthesiology, 1972